Connection

Mark Kindy to Oligopeptides

This is a "connection" page, showing publications Mark Kindy has written about Oligopeptides.
Connection Strength

0.963
  1. GM6 Attenuates Alzheimer's Disease Pathology in APP Mice. Mol Neurobiol. 2019 Sep; 56(9):6386-6396.
    View in: PubMed
    Score: 0.590
  2. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007 Sep; 388(9):979-83.
    View in: PubMed
    Score: 0.266
  3. Delta 2-specific opioid receptor agonist and hibernating woodchuck plasma fraction provide ischemic neuroprotection. Acad Emerg Med. 2008 Mar; 15(3):250-7.
    View in: PubMed
    Score: 0.069
  4. Enzyme-linked immunosorbent assay for an octapeptide based on a genetically engineered fusion protein. Anal Chem. 1993 May 01; 65(9):1147-51.
    View in: PubMed
    Score: 0.025
  5. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003 Jul; 9(7):907-13.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.